enVVeno Medical (NVNO) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
VolitionRX is the larger company by market cap ($6.7 million vs $6.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NVNO | VNRX |
|---|---|---|
| Share price | $9.22 | $0.2234 |
| Market cap | $6.41M | $6.72M |
| 1-day change | +9.29% | +1.81% |
| EPS (TTM) | $-24.99 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.80 | $10.40 |
| 52-week low | $7.01 | $0.22 |
| Distance from 52-week high | -70.06% | -97.85% |
| Analyst consensus | none | none |
| Avg. price target upside | +225.38% | +5996.69% |
| Average volume | 23.71K | 8.47M |
| Shares outstanding | 694.83K | 30.06M |
| Employees | 33 | 57 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About enVVeno Medical
NVNO stock →enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency.
Health Care · Medical/Dental Instruments · 33 employees
About VolitionRX
VNRX stock →VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 57 employees
NVNO vs VNRX FAQ
Which is bigger, enVVeno Medical or VolitionRX?
VolitionRX (VNRX) is larger, with a market capitalization of $6.72M compared with $6.41M for enVVeno Medical (NVNO).
Are enVVeno Medical and VolitionRX in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for enVVeno Medical and Biotechnology: In Vitro & In Vivo Diagnostic Substances for VolitionRX.